Aztreonam contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Aztreonam}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AZACTAM (AZTREONAM) INJECTION, POWDER, FOR SO..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AZACTAM (AZTREONAM) INJECTION, POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AZACTAM (AZTREONAM) INJECTION, POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 00:04, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation.
References
Adapted from the FDA Package Insert.